Business Context and Reporting Period
This Form 8-K is a current report filed by Bio-Rad Laboratories, Inc. on September 29, 2025. The filing serves to disclose a significant corporate event regarding the company's leadership and history.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is not a financial statement filing and contains no quantitative financial data.
Material Changes
The material change reported is the passing of Alice N. Schwartz, the Company's co-founder and Director Emeritus, on September 25, 2025, at the age of 99.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The disclosure is strictly limited to the announcement of the co-founder's death.
Key Facts for Investors
- Event: Death of co-founder and Director Emeritus Alice N. Schwartz.
- Date of Event: September 25, 2025.
- Announcement Date: September 29, 2025.
- Financial Impact: No financial impact or metrics are disclosed in this specific filing.
- Reference: A press release detailing the announcement is included as Exhibit 99.1.